55KRC highlights Ovarian Cancer Awareness Month
UC expert says vague symptoms demonstrate importance of developing screening test
September is Ovarian Cancer Awareness Month, highlighting the fifth most deadly cancer among women, according to the American Cancer Society.
Ovarian cancers are aggressive and can grow quickly, according to Amanda Jackson, MD, associate professor, director of gynecologic oncology and vice chair of gynecology in the College of Medicine and a UC Health physician.
Symptoms of ovarian cancer are often vague, including bloating, constipation and women reporting feeling full, Jackson said. The combination of the cancer's aggressiveness and the common symptoms makes it especially important to find a better screening test.
Jackson was a guest on Simply Medicine, 55KRC, discussing the symptoms and treatment of ovarian cancer in more detail.
Note: Interview begins at the 31:26 mark.
Featured photo courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.